Treatment of cardiomyopathy and rhabdomyolysis in long-chain fat oxidation disorders using an anaplerotic odd-chain triglyceride
Charles R. Roe, … , France David, Henri Brunengraber
Charles R. Roe, … , France David, Henri Brunengraber
Published July 15, 2002
Citation Information: J Clin Invest. 2002;110(2):259-269. https://doi.org/10.1172/JCI15311.
View: Text | PDF
Article Genetics

Treatment of cardiomyopathy and rhabdomyolysis in long-chain fat oxidation disorders using an anaplerotic odd-chain triglyceride

Abstract

Research Article

Authors

Charles R. Roe, Lawrence Sweetman, Diane S. Roe, France David, Henri Brunengraber

×

Figure 1

Options: View larger image (or click on image) Download as PowerPoint
Production of [3-2H3]propionylcarnitine from C7, C9, and C15 by cultured...
Production of [3-2H3]propionylcarnitine from C7, C9, and C15 by cultured fibroblasts from the VLCAD patient (black bars) and 50 control subjects (white bars, mean ± SE).